BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
239 hedge funds and large institutions have $8.78B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2022 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 85 increasing their positions, 96 reducing their positions, and 115 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
239
Holders Change
-89
Holders Change %
-27.13%
% of All Funds
4.13%
Holding in Top 10
32
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+6.67%
% of All Funds
0.55%
New
28
Increased
85
Reduced
96
Closed
115
Calls
$596M
Puts
$265M
Net Calls
+$331M
Net Calls Change
+$292M
Top Buyers
| 1 |
HI
HBK Investments
Dallas,
Texas
|
$537M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
$572M |
| 3 |
JPMorgan Chase & Co
New York
|
$309M |
| 4 |
GCL
Glazer Capital LLC
New York
|
$187M |
| 5 |
SFM
Soros Fund Management
New York
|
$344M |
